Ten PhD Students Of University Of Hyderabad Selected For Prime Minister Research Fellowship (PMRF)
Ten PhD Students Of University Of Hyderabad Selected For Prime Minister Research Fellowship (PMRF)
University of Hyderabad: While two scholars each from School of Chemistry and School of Life Sciences have been selected for PMRF, three students each from School of Engineering Sciences and Technology and School of Physics have also been shortlisted.
Education | Written By Mridusmita Deka | Updated: May 23, 2021 12:45 pm IST
RELATED NEWS
New Delhi:
Ten PhD students of the University of Hyderabad has been selected for the Prime Minister Research Fellowship (PMRF). All the ten fellows under the PMRF scheme will receive a starting monthly fellowship of Rs 70,000, which may increase to a maximum monthly fellowship of Rs 80,000 towards the end of PhD, provided the performance during the initial years o
Sunyatee International Foundation, a non-governmental organisation, has donated two oxygen concentrators and 3,000 N-95 masks to the University of Hyderabad (UoH) as a part of their support to COVID-1
Updated:
May 11, 2021 09:23 IST
Infection Control Academy president writes to KTR, says current dashboard doesn’t support patients or decision makers
Share Article
AAA
Citizens waiting at a free COVID-19 testing facility at a fever hospital in Hyderabad on Monday, May 10, 2021.
| Photo Credit: RAMAKRISHNA G
Infection Control Academy president writes to KTR, says current dashboard doesn’t support patients or decision makers
A State-wide real-time bed availability Dashboard, along with a call centre for COVID triage (sorting) with operators routing the patients based on a simple questionnaire, will enormously reduce the pressure on healthcare workers and unclutter the overcrowded healthcare facilities, said Infection Control Academy of India president B. Ranga Reddy.
Hyderabad varsity startup develops stem cell-based treatment for Covid
Top Searches:
IANS | Updated: May 4, 2021, 09:46 IST
A biotech startup company, incubated at the ASPIRE-Technology Business Incubator (ASPIRE-TBI), University of Hyderabad (UoH), on Monday announced a human umbilical cord (UC) tissue harvested and clinically processed adult Mesenchymal Stem Cells (MSCs) based therapy for Covid patients.
Picture used for representational purpose only
HYDERABAD: A biotech startup company, incubated at the ASPIRE-Technology Business Incubator (ASPIRE-TBI), University of Hyderabad (UoH), on Monday announced a human umbilical cord (UC) tissue harvested and clinically processed adult Mesenchymal Stem Cells (MSCs) based therapy for Covid patients.
Transcell Oncologics has developed a proprietary cell-based platform technology, HEMATO UC-MSCs, with anti-cytokine storm properties, anti-inflammatory attributes and repairing abilities.
Significantly improved patient survival and time to recovery observed following the treatment, says Transcell Oncologics
A breakthrough human Umbilical Cord (UC) tissue harvested and clinically processed adult Mesenchymal Stem Cells (MSCs)-based therapy to COVID patients has been announced by Transcell Oncologics,
a biotech start-up company, incubated at ASPIRE-Technology Business Incubator (ASPIRE-TBI), University of Hyderabad (UoH) on Monday.
The firm had developed proprietary cell-based platform technology ‘HEMATO UC-MSCs’ with anti-cytokine storm properties, anti-inflammatory attributes and repairing abilities. The research recommends HEMATO UC-MSCs to be administered as “two intravenous infusions, at a dose of 100 million cells per infusion, given 72 hours apart to the COVID patients.